Page 2

Recently published articles about Difficult to Treat Depression

JCP
Surgical Interventions in Treatment Resistant Depression
Insights

October 7, 2024

Patricio Riva Posse, MD, discusses advanced surgical interventions for treatment-resistant depression, including vagus nerve and deep brain stimulation. This presentation explores relapse rates, alternative therapies, and the potential for...
JCP
Neurosteroids and Postpartum Depression
Insights

October 7, 2024

In this video, Samantha Meltzer-Brody, MD, MPH, discusses the use of brexanolone and zuranolone, novel neurosteroids for treating postpartum depression, focusing on their mechanisms, rapid efficacy, and clinical trial...
Study Highlights Increased Mortality Risks in Difficult-to-Treat Depression
news

October 1, 2024

A new study reveals that treatment-resistant depression (TRD) significantly increases mortality risk, particularly from external causes.
JCP
Algorithms for TRD Treatment Success
Insights

September 27, 2024

Dr. Nolan Williams delves into the innovative Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treating resistant depression. Explore groundbreaking research, clinical trials, and the transformative potential of personalized brain...
Abbott Launches Clinical Study for New Depression Treatment
news

September 17, 2024

Abbott has launched a study to evaluate its new deep brain stimulation device's ability to treat difficult-to-treat depression.
Weekly Mind Reader: Treatment Options Face Off
news

September 6, 2024

This week includes a test of treatment options, a case report of intolerable nausea, and our new series on difficult-to-treat depression.
Study Reveals Differences Between Psilocybin, Escitalopram in Depression Treatment
news

August 30, 2024

New research explores how psilocybin therapy and escitalopram alter brain dynamics in different ways to treat depression.
Esmethadone Shows Potential in Difficult-to-Treat Depression
news

August 29, 2024

Esmethadone showed mixed results in phase 3 trials with promising response and remission rates, especially in severe cases.
New Research Uncovers Six Depression Subtypes
news

August 27, 2024

Stanford research shows that advanced brain imaging and AI can identify depression biotypes, enabling more effective treatment options.
JCP
Algorithms for TRD Treatment Success
Insights

July 12, 2024

Ilse Wiechers presents an in-depth exploration of advanced neuromodulation techniques for treating difficult-to-treat depression. Discover cutting-edge research, clinical applications, and the latest insights on personalized brain stimulation approaches aimed...
JCP
Access in Interventional Psychiatry
Insights

July 12, 2024

Dr. Lisa M. Harding discusses the latest advancements in neuroimaging and personalized treatment strategies for difficult-to-treat depression. Learn about cutting-edge research, diagnostic tools, and targeted therapies that are paving...
JCP
Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts
Original Research

July 8, 2024

A single infusion of low-dose ketamine resulted in a brief (~4 hour) yet significant reduction in hopelessness.
, , , et al

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe